调度员辅助心肺复苏对院外心脏骤停神经功能完好存活的影响:一项系统评价
该系统评价按PRISMA指南检索PubMed(MEDLINE)、EMBASE和Cochrane Library数据库,纳入比较调度员辅助心肺复苏与旁观者启动心肺复苏或无旁观者心肺复苏的成人及/或儿童院外心脏骤停研究,主要结局为出院时或1个月及以上神经功能完好存活。检索获得4742条引文,33项研究符合纳入标准,因研究人群重叠最终纳入14项观察性研究,偏倚风险采用纽卡斯尔-渥太华量表评价,各研究得分6至9分。出院时神经功能完好存活率中位数:调度员辅助心肺复苏7.0%(IQR 5.1-10.8%),旁观者启动心肺复苏7.5%(IQR 6.6-10.2%),无旁观者心肺复苏4.4%(IQR 2.0-9.0%)(4项研究);1个月时:调度员辅助心肺复苏3.1%(IQR 1.6-3.4%),旁观者启动心肺复苏5.7%(IQR 5.0-6.0%),无旁观者心肺复苏2.5%(IQR 2.1-2.6%)(3项研究)。结论认为早期心肺复苏至关重要,在旁观者未启动心肺复苏的情况下,调度员辅助心肺复苏提供改善神经功能完好存活的机会。
要点
- 出院时神经功能完好存活率中位数:调度员辅助心肺复苏7.0%(IQR 5.1-10.8%),旁观者启动心肺复苏7.5%(IQR 6.6-10.2%),无旁观者心肺复苏4.4%(IQR 2.0-9.0%)(4项研究)。
- 1个月时神经功能完好存活率中位数:调度员辅助心肺复苏3.1%(IQR 1.6-3.4%),旁观者启动心肺复苏5.7%(IQR 5.0-6.0%),无旁观者心肺复苏2.5%(IQR 2.1-2.6%)(3项研究)。
- 调度员辅助心肺复苏和旁观者启动心肺复苏均较无旁观者心肺复苏提高神经功能完好存活率,但调度员辅助心肺复苏结局劣于旁观者启动心肺复苏。
- 早期心肺复苏至关重要;在旁观者未启动心肺复苏的情况下,调度员辅助心肺复苏提供改善院外心脏骤停后神经功能完好存活的机会。
- 纳入研究均为观察性研究,研究人群异质,部分研究仅报告有目击的心脏骤停、心源性心脏骤停和/或可电击心律。
适用人群与场景
- 成人及/或儿童院外心脏骤停患者;研究人群异质,包括成人、儿童及混合人群。
- 部分研究仅纳入有目击的心脏骤停、心源性心脏骤停和/或可电击心律的患者。
研究设计与关键结果
- 系统评价按PRISMA指南进行,检索PubMed(MEDLINE)、EMBASE和Cochrane Library数据库,检索获得4742条引文,33项研究符合纳入标准,因研究人群重叠最终纳入14项观察性研究。
- 主要结局为出院时、1个月或更长时间神经功能完好存活;偏倚风险采用纽卡斯尔-渥太华量表评价,各研究得分6至9分。
- 出院时神经功能完好存活率中位数:调度员辅助心肺复苏7.0%(IQR 5.1-10.8%),旁观者启动心肺复苏7.5%(IQR 6.6-10.2%),无旁观者心肺复苏4.4%(IQR 2.0-9.0%)(4项研究)。
- 1个月时神经功能完好存活率中位数:调度员辅助心肺复苏3.1%(IQR 1.6-3.4%),旁观者启动心肺复苏5.7%(IQR 5.0-6.0%),无旁观者心肺复苏2.5%(IQR 2.1-2.6%)(3项研究)。
证据类型、等级与局限
- 证据类型:系统评价,纳入研究均为观察性研究。
- 偏倚风险采用纽卡斯尔-渥太华量表评价,各研究得分6至9分。
- 局限:研究间院外心脏骤停结局存在变异,并识别出多种混杂因素。
对床旁实践的改变
- 调度员辅助心肺复苏和旁观者启动心肺复苏均较无旁观者心肺复苏提高神经功能完好存活率。
- 调度员辅助心肺复苏结局劣于旁观者启动心肺复苏;早期心肺复苏至关重要,在旁观者未启动心肺复苏的情况下,调度员辅助心肺复苏提供改善神经功能完好存活的机会。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Dispatcher-assisted cardiopulmonary resuscitation (DA-CPR) increases neurologically intact survival in out-of-hospital cardiac arrest (OHCA) according to several studies. This systematic review summarizes neurologically intact survival outcomes of DA-CPR in comparison with bystander-initiated CPR and no bystander CPR in OHCA.
METHODS: The systematic review was conducted according to the PRISMA guidelines. All studies including adult and/or pediatric OHCAs that compared DA-CPR with bystander-initiated CPR or no bystander CPR were included. Primary outcome was neurologically intact survival at discharge, one-month or longer. Studies were searched for in PubMed (MEDLINE), EMBASE, and the Cochrane Library databases. The risk of bias was evaluated using the Newcastle-Ottawa Scale.
RESULTS: The search string generated 4742 citations of which 33 studies were eligible for inclusion. Due to overlapping study populations, the review included 14 studies. All studies were observational. The study populations were heterogeneous and included adult, pediatric and mixed populations. Some studies reported only witnessed cardiac arrests, arrests of cardiac ethiology, and/or shockable rhythm. The individual studies scored between six and nine on the Newcastle-Ottawa Scale of risk of bias. The median neurologically intact survival at hospital discharge with DA-CPR was 7.0% (interquartile range (IQR): 5.1-10.8%), with bystander-initiated CPR 7.5% (IQR: 6.6-10.2%), and with no bystander CPR 4.4% (IQR: 2.0-9.0%) (four studies). At one-month neurologically intact survival with DA-CPR was 3.1% (IQR: 1.6-3.4%), with bystander-initiated CPR 5.7% (IQR: 5.0-6.0%), and with no bystander CPR 2.5% (IQR: 2.1-2.6%) (three studies).
CONCLUSION: Both DA-CPR and bystander-initiated CPR increase neurologically intact survival compared with no bystander CPR. However, DA-CPR demonstrates inferior outcomes compared with bystander-initiated CPR. Early CPR is crucial, thus in cases where bystanders have not initiated CPR, DA-CPR provides an opportunity to improve neurologically intact survival following OHCA. Variability in OHCA outcomes across studies and multiple confounding factors were identified.
参考来源
- Eberhard KE, Linderoth G, Gregers MCT, et al. Impact of dispatcher-assisted cardiopulmonary resuscitation on neurologically intact survival in out-of-hospital cardiac arrest: a systematic review. Scand J Trauma Resusc Emerg Med. 2021. PMID: 34030706. doi:10.1186/s13049-021-00875-5
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。